David has experience creating press materials, key message documents, corporate positioning and messaging, white papers, fact sheets, white papers, blogs, and feature articles. David has also created content for several corporate and product web sites.
David has worked with pharmaceutical and biotechnology companies, diagnostics companies and medical device companies. He has helped to launch several new drugs, diagnostics and medical devices for companies including Eisai, AstraZeneca, Aerocrine, Fujirebio Diagnostics, GE Healthcare and Novartis.
Healthcare, pharmaceuticals, biotechnology, diagnostics, medical devices, clinical trial data, patient materials, patient advocacy, public health, cancer treatment, cancer diagnostics, respiratory disease, asthma, COPD, heart disease, cardiovascular disease, autoimmune disease, diabetes, FDA approvals, FDA advisory committee meetings, social media posts, medical/legal review, strategic plans, scopes of work, proposals, presentations, video scripts, rewrites.
David has spent most of my career in the public relations, marketing services, medical communications and consulting industries. This experience includes working at leading international advertising and marketing services holding companies in client services and business development leadership roles, In addition to starting two of his own strategic communications businesses, he has written extensively on communications strategy, client services leadership, business and corporate leadership, entrepreneurship and business trends.
His work for pharmaceutical companies includes product launches, medical affairs consulting and content, product franchise messaging and positioning, strategic plans, launch strategy, FDA advisory committee meetings, regulatory milestones, medical congress support, and more.
David has been working in healthcare for more than 20 years. During this time, he has worked with pharmaceutical companies, academic institutions, medical schools, hospitals, medical societies, patient advocacy groups and healthcare-focused social media channels.
David has worked with pharmaceutical, medical technology, biotechnology and diagnostics companies for more than 20 years. His writing experience includes strategic documents, presentations, plans, and scopes of work. It also includes the ideation and creation of finished products, including web sites, press materials, bylined articles, digital and print brochures, white papers, blogs and thought leadership content, in addition to posts on most social media channels.
David has been writing press releases, Q&A documents, key messages and disease backgrounders for over 20 years. Clients have included companies in the pharmaceutical, biotechnology, diagnostics and medial device industries. David has also written press materials for patient advocacy groups and his own start-up consulting companies.
David has been blogging since the early 2000's. He has written blogs for two companies that he started and built, one with a business partner and one on his own. David has also been invited to submit blogs as a thought leader to other company web sites and social media channels.
David has created and delivered hundreds of presentations over the past 20 years. These presentations include competitive pitch proposals for new drug launches, strategic plans to support the communications needs of pharmaceutical business units and product franchises, advisory board slide decks, presentation training decks, learning and development slide content and internal presentations for clients.
David has written case studies demonstrating patient outcomes, business challenges and solutions, therapeutic area experience, crisis management and resolution, and global strategic challenges, solutions and outcomes. David has worked in global communications consultancies specializing in healthcare, and he has also worked for two pharmaceutical companies in communications leadership roles.
David has written bios and profiles for physicians, healthcare professionals, researchers and leaders in medicine and health. These bios and profiles have been featured in corporate presentations, web sites, advisory board materials, white papers and brochures.
David has written articles for pharmaceutical industry magazines, client trial services magazines, corporate intranet sites, social media channels and corporate web sites. He has published several thought pieces on the emergence of personalized medicine, targeted cancer therapies, new technology and its impact on healthcare communications, and biopharmaceutical industry trends, mergers and acquisitions.
David has written several white papers. Topics include the emergence of personalized medicine in cancer treatment, a vision for the future of cancer treatment, trends in healthcare and life sciences marketing, new business models in the marketing, public relations and advertising industries, and the impact of new technologies on healthcare, research and development, and marketing services.